Pharmaceutical

Prendio-BioProcure Strengthens Leadership Team with Four Strategic Appointments, Accelerating Innovation and Growth

BURLINGTON, Mass., Sept. 19, 2024 /PRNewswire/ -- Prendio-BioProcure, a leader in procurement solutions for the life sciences industry, is thrilled…

4 months ago

Autoradiography Films Market to Reach $174.9 Million, Globally, by 2033 at 3% CAGR: Allied Market Research

Increase in prevalence of chronic diseases, surge in technological advancements, and rise in R&D activities in the healthcare sector are…

4 months ago

Physiotherapy Equipment Market is expected to generate a revenue of USD 14.88 Billion by 2031, Globally, at 6.6% CAGR: Verified Market Research®

Verified Market Research® proudly announces the release of its latest comprehensive market research report, "Physiotherapy Equipment Market," offering critical insights…

4 months ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

4 months ago

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

Published data shows that chemotherapy delivered via TAMP with prior chemoradiation in Locally Advanced Pancreatic Cancer observed an Overall Survival…

4 months ago

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Topline results expected in fourth quarter of 2024GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:…

4 months ago

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer

Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and regulatory…

4 months ago

Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors

Company actively advancing lead ophthalmology drug candidate to first Investigational New Drug (IND) filingREDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE…

4 months ago

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a…

4 months ago

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded…

4 months ago